Literature DB >> 9346972

Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung.

J Li1, A Hagner-McWhirter, L Kjellén, J Palgi, M Jalkanen, U Lindahl.   

Abstract

Glucuronyl C5-epimerases catalyze the conversion of D-glucuronic acid (GlcUA) to L-iduronic acid (IdceA) units during the biosynthesis of glycosaminoglycans. An epimerase implicated in the generation of heparin/heparan sulfate was previously purified to homogeneity from bovine liver (Campbell, P., Hannesson, H. H., Sandbäck, D., Rodén, L., Lindahl, U., and Li, J.-p. (1994) J. Biol. Chem. 269, 26953-26958). The present report describes the molecular cloning and functional expression of the lung enzyme. The cloned enzyme contains 444 amino acid residues and has a molecular mass of 49,905 Da. N-terminal sequence analysis of the isolated liver enzyme showed this species to be a truncated form lacking a 73-residue N-terminal domain of the deduced amino acid sequence. The coding cDNA insert was cloned into a baculovirus expression vector and expressed in Sf9 insect cells. Cells infected with recombinant epimerase showed a 20-30-fold increase in enzyme activity, measured as release of 3H2O from a polysaccharide substrate containing C5-3H-labeled hexuronic acid units. Furthermore, incubation of the expressed protein with the appropriate (GlcUA-GlcNSO3)n substrate resulted in conversion of approximately 20% of the GlcUA units into IdceA residues. Northern analysis implicated two epimerase transcripts in both bovine lung and liver tissues, a dominant approximately 9-kilobase (kb) mRNA and a minor approximately 5-kb species. Mouse mastocytoma cells showed only the approximately 5-kb transcript. A comparison of the cloned epimerase with the enzymes catalyzing an analogous reaction in alginate biosynthesis revealed no apparent amino acid sequence similarity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346972     DOI: 10.1074/jbc.272.44.28158

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Controlled Chemoenzymatic Synthesis of Heparan Sulfate Oligosaccharides.

Authors:  Weigang Lu; Chengli Zong; Pradeep Chopra; Lauren E Pepi; Yongmei Xu; I Jonathan Amster; Jian Liu; Geert-Jan Boons
Journal:  Angew Chem Int Ed Engl       Date:  2018-03-30       Impact factor: 15.336

Review 2.  CS lyases: structure, activity, and applications in analysis and the treatment of diseases.

Authors:  Robert J Linhardt; Fikri Y Avci; Toshihiko Toida; Yeong Shik Kim; Miroslaw Cygler
Journal:  Adv Pharmacol       Date:  2006

3.  Fibroblast growth factor-based signaling through synthetic heparan sulfate blocks copolymers studied using high cell density three-dimensional cell printing.

Authors:  Eric Sterner; Sayaka Masuko; Guoyun Li; Lingyun Li; Dixy E Green; Nigel J Otto; Yongmei Xu; Paul L DeAngelis; Jian Liu; Jonathan S Dordick; Robert J Linhardt
Journal:  J Biol Chem       Date:  2014-02-22       Impact factor: 5.157

4.  Hydrogen/deuterium exchange-LC-MS approach to characterize the action of heparan sulfate C5-epimerase.

Authors:  Ponnusamy Babu; Xylophone V Victor; Emily Nelsen; Thao Kim Nu Nguyen; Karthik Raman; Balagurunathan Kuberan
Journal:  Anal Bioanal Chem       Date:  2011-05-15       Impact factor: 4.142

5.  Control of the heparosan N-deacetylation leads to an improved bioengineered heparin.

Authors:  Zhenyu Wang; Bo Yang; Zhenqing Zhang; Mellisa Ly; Majde Takieddin; Shaker Mousa; Jian Liu; Jonathan S Dordick; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2011-04-12       Impact factor: 4.813

6.  Using engineered 2-O-sulfotransferase to determine the activity of heparan sulfate C5-epimerase and its mutants.

Authors:  Kai Li; Heather N Bethea; Jian Liu
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

7.  Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells.

Authors:  Tatiana Y Prudnikova; Liudmila A Mostovich; Natalia V Domanitskaya; Tatiana V Pavlova; Vladimir I Kashuba; Eugene R Zabarovsky; Elvira V Grigorieva
Journal:  Cancer Cell Int       Date:  2010-08-19       Impact factor: 5.722

Review 8.  Heparan sulfate biosynthesis: regulation and variability.

Authors:  Johan Kreuger; Lena Kjellén
Journal:  J Histochem Cytochem       Date:  2012-10-04       Impact factor: 2.479

Review 9.  The design and synthesis of new synthetic low-molecular-weight heparins.

Authors:  K Chandarajoti; J Liu; R Pawlinski
Journal:  J Thromb Haemost       Date:  2016-04-15       Impact factor: 5.824

10.  Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.

Authors:  Jinghua Chen; Courtney L Jones; Jian Liu
Journal:  Chem Biol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.